Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Current Assets (2016 - 2025)

Conmed (CNMD) has disclosed Current Assets for 16 consecutive years, with $672.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 5.13% year-over-year to $672.9 million, compared with a TTM value of $672.9 million through Dec 2025, up 5.13%, and an annual FY2025 reading of $672.9 million, up 5.13% over the prior year.
  • Current Assets was $672.9 million for Q4 2025 at Conmed, up from $662.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $672.9 million in Q4 2025 and bottomed at $424.4 million in Q1 2021.
  • Average Current Assets over 5 years is $581.6 million, with a median of $615.6 million recorded in 2023.
  • The sharpest move saw Current Assets skyrocketed 30.24% in 2022, then grew 0.52% in 2025.
  • Year by year, Current Assets stood at $460.1 million in 2021, then grew by 26.32% to $581.2 million in 2022, then increased by 5.92% to $615.6 million in 2023, then increased by 3.96% to $640.0 million in 2024, then increased by 5.13% to $672.9 million in 2025.
  • Business Quant data shows Current Assets for CNMD at $672.9 million in Q4 2025, $662.2 million in Q3 2025, and $657.8 million in Q2 2025.